Takeda Indonesia

Takeda Indonesia Company Introduction

Takeda Indonesia is a subsidiary of Takeda Pharmaceutical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. The company focuses on delivering innovative medicines and vaccines to patients in Indonesia, aiming to improve health and quality of life.

Takeda Indonesia is primarily a manufacturer. It operates a manufacturing facility in Pulogadung, Jakarta, where it produces a range of pharmaceutical products and vaccines for the local market. In addition to manufacturing, Takeda Indonesia also functions as a distributor and trader, responsible for the sales, marketing, and distribution of its locally produced medicines as well as imported Takeda products across various therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, and plasma-derived therapies.

Classification: Manufacturer and Trader/Distributor.

Takeda Indonesia

Takeda Indonesia produces and sells a range of pharmaceutical products. While specific product availability can vary by region and evolve over time, their portfolio generally includes:

**Oncology**

* Iclusig (ponatinib)

* Ninlaro (ixazomib)

* Velcade (bortezomib)

**Gastroenterology**

* Entyvio (vedolizumab)

**Rare Diseases**

* Firazyr (icatibant)

* Takhzyro (lanadelumab)

* Vowst (fecal microbiota spores, live-L donaldson)

**Plasma-Derived Therapies**

* Albumin

* Immune Globulin (IVIG)

* Various clotting factors